Despite these limitations, the study makes significant contributions by validating the upregulation of LINC01206 in psoriatic lesions and its downregulation following glucocorticoid treatment, suggesting its potential as a therapeutic target, and by mechanistically linking LINC01206 to EHF, revealing a previously unknown pathway in psoriasis pathogenesis. This evidence concerns the gene EHF and psoriasis.